"National Jewish Health Western Hematology-Oncology is a satellite location of National Jewish Health in Golden, Colo. We specialize in the treatment of cancer and blood disorders. We provide the full spectrum of care from cancer screening to cancer diagnosis and treatment in the Denver metro area. Patients have access to internationally renowned specialists, leading-edge technology and advanced treatments and research."

During the past decade, National Jewish Health-Western Hematology Oncology conducted 87 clinical trials. In the 10-year time frame, 87 clinical trials started and 26 clinical trials were completed, i.e. on average, 29.9% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 25 clinical trials were completed. i.e. 119% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Jewish Health-Western Hematology Oncology" #1 sponsor was "National Cancer Institute (NCI)" with 45 trials, followed by "SWOG Cancer Research Network" with 19 trials sponsored, "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored and "NRG Oncology" with 10 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Jewish Health-Western Hematology Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 48 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "National Jewish Health-Western Hematology Oncology" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Invasive Breast Carcinoma" (6 trials), "Stage IIIA Breast Cancer" (6 trials) and "Stage IV Lung Cancer AJCC v8" (6 trials). Many other conditions were trialed in "National Jewish Health-Western Hematology Oncology" in a lesser frequency.

Most popular intervention types in "National Jewish Health-Western Hematology Oncology" are "Drug" (68 trials), "Other" (65 trials), "Biological" (47 trials), "Procedure" (34 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (32 trials), "Quality-of-Life Assessment" (27 trials), "Biospecimen Collection" (20 trials), "Computed Tomography" (19 trials) and "Questionnaire Administration" (19 trials). Other intervention names were less common.

The vast majority of trials in "National Jewish Health-Western Hematology Oncology" are 83 trials for "All" genders, 11 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "National Jewish Health-Western Hematology Oncology". undefined are not yet recruiting, 22 are recruiting, 51 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in National Jewish Health-Western Hematology Oncology, 4 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in National Jewish Health-Western Hematology Oncology, 1 "Phase 1" clinical trials were conducted, 45 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".